long, believe with the countrywide and lynch buys; the future holds great possibilities. accumulate on pull backs.possible divident producer

global presence will be a positive when economy picks up. buy on dips possible divident producer

commercial banking, as bussiness improves so will thier bussiness gain market share.could be a divident waiting to see if they participant in ppip

low debt,access to china market,one of the largess mag distributors with a possible line into us market. increase in new contracts

china market, low debt.new manufacturing plant access to cheap high grade ore. auto sales increasing in china up 39% manufactures cold roll steel plates

stem cell therapy (esct)quite a few patents, low debt,recent agreement with gehc.phase 1 clinical trails to start with fda approval for human trails. i feel positive about geron with two licensing agreements with large deep pockets it seems up is the direction

stem cell;adult stem cell therapy. testing on animals now with great results it is small enough to still be a candidate for a buy out

stem cell; a company that is focusing on stem cell delivery methods. a candidate for a buy out